Sugar Editorial Picks
Aug 07, 2007 -
Raise your hand if you watched Fat March on ABC last night....
My hand is raised but not proudly. As one of the biggest fans of The Biggest Loser, Fat March could have also been one of my favorites, however it didn't even come close.
- 14 Comments
Aug 06, 2007 -
That's Fit wants to help you recover quickly from your workout, so you are excited to get out there and do it again.
iFit&Healthy has the skinny on Bravo's Workout Rebecca Cardon's workout. Let me tell you this girl can bench press!
- 0 Comments
Jun 14, 2007 -
- Donald Trump and Fox are planning a show called "Lady or a Tramp," in which rowdy, bawdy party girls will be sent to charm school and taught proper manners. Great, because 1) when I think manners, I think Trump, and 2) I really needed another reality show to showcase the worst of womankind. They'd never do a show like this with partyboys, would they?
- ABC is filming a reality series in which overweight people will walk from Boston to Washington, D.C.
- 6 Comments
Other Search Results
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Biological and Medical Caus...
- Cultural and Emotional Caus...
- Risk Factors
- Complications
- Weight Loss and Maintenance...
- Weight Management
- Medications
- Other Treatments
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Cancer and Weight Control:
- Cancer prevention guidelines from the American Cancer Society stress the importance of maintaining a healthy weight throughout life. A healthy weight is even more important than eating specific healthy foods, when it comes to cancer prevention.
Drug Warning:
- The US Food and Drug Administration (FDA) is warning consumers not to buy a product known as the "Brazilian diet pill." This product is labeled as a dietary supplement, but contains several chemicals found in powerful prescription drugs.
- 1 Comment
Oct 08, 2008 -
Overview
- Signs and Symptoms
- Causes
- Risk Factors
- Diagnosis
- Preventive Care
- Treatment Approach
- Other Considerations
- Supporting Research
HEALTH GUIDE REFERENCE FROM A.D.A.M
Hypercholesterolemia, or high cholesterol, occurs when there is too much cholesterol in the body. Cholesterol is a soft, waxy, fat-like substance that is a natural component of all the cells of the body. Your body makes all the cholesterol it needs.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Causes
- Symptoms
- Risk Factors
- Dietary Factors
- Prevention
- Diagnosis
- Staging
- Prognosis
- Surgery
- Medications
- Radiation Treatment
- Follow-up Testing
- Treatment for Metastasized ...
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Drug Approval
In September 2006, the Food and Drug Administration approved panitumumab (Vectibix) for the treatment of patients with colorectal cancer that has spread to other parts of the body following chemotherapy. Like cetuximab (Ertibux), panitumumab targets the epidermal growth factor receptor (EGFR) on cancer cells. Panitumumab is the first new colorectal cancer drug approved since 2004.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Risk Factors
- Prevention and Lifestyle Fa...
- Symptoms
- Diagnosis
- Prognosis
- Treatment
- Surgery
- Radiation
- Medications
- Chemotherapy
- Hormone Therapy
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Drug Approvals
- In September 2007, Evista (raloxifene) was approved for prevention of breast cancer in postmenopausal women with osteoporosis, and postmenopausal women at high risk for invasive breast cancer. Raloxifene and tamoxifen are the only two drugs approved for breast cancer prevention in high-risk women.
- In March 2007, lapatinib (Tykerb) was approved in combination with capecitabine (Xeloda) for treatment of advanced HER2-positive breast cancer.
- In November 2006, trastuzumab (Herceptin) was approved for treatment of early-stage HER2-positive breast cancer. Trastuzumab is also approved for advanced HER2-positive breast cancer.
Screening
- The American College of Physicians’ 2007 guidelines recommend that women with a low risk for breast cancer talk to their doctor before starting to have mammogram screening at age 40.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Complications
- Symptoms
- Lifestyle Changes
- Medications
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Black Cohosh Doesn’t Help Hot Flashes
- The herbal remedy black cohosh is no better than placebo for treating hot flashes and night sweats, according to a 2006 study in the Annals of Internal Medicine.
- Most complementary and alternative medicines are ineffective for relieving menopausal symptoms, according to a 2006 review in the Archives of Internal Medicine.
Hormone Replacement Therapy (HRT)
- Short-term use of HRT remains an option for recently menopausal women who have a low risk for stroke, according to a 2007 statement from the North American Menopause Society (NAMS). However, NAMS recommends that women who are at risk for heart disease or breast cancer should consider other approaches for managing hot flashes.
- For women who want to discontinue HRT, gradually tapering off the medication or stopping it abruptly appears to make little difference in the recurrence of symptoms, suggests a 2006 study. A gradual approach may delay the reappearance of symptoms, but does not prevent them from returning.
HRT and Heart Disease: Timing Counts
Women who begin HRT within 10 years of menopause have a much lower risk for heart disease and heart attack than women who start HRT later on, indicates a 2007 study in the Journal of the American Medical Association.
- 0 Comments
Feb 09, 2009 -
Feeling the sting from other chains such as McDonald's and Dunkin' Donuts, a desperate Starbucks announced last week that it will soon be introducing value meals of its own. The chain plans to launch value pairings in all its company-owned US stores on March 3. Although regular prices for food and drink items vary by store location, Starbucks claims the pairings will provide customers with an average savings of as much as $1.20.
- 13 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Symptoms
- Risk Factors
- Complications
- Diagnosis
- Treatment
- Levadopa (L-dopa)
- Other Medications
- Surgery
- Lifestyle Changes
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Drug Approvals
- In 2007, the FDA approved the first skin patch drug for treatment of Parkinson’s disease. Transdermal rotigotine (Neupro) is a dopamine agonist drug that may help improve symptoms of early-stage Parkinson’s disease. The patch is applied daily.
- Rivastigimine (Exelon), an Alzheimer’s disease drug, was approved in 2006 for treatment of mild-to-moderate dementia associated with Parkinson’s disease.
Drug Withdrawal
In 2007, the FDA withdrew the dopamine agonist pergolide (Permax) from the market due to safety concerns.
- 2 Comments